U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H22F3N9
Molecular Weight 421.4228
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N2-(3-(2-(2H-1,2,3-triazol-2-yl)propan-2-yl)-1-cyclopropyl-1H-pyrazol-5-yl)N4-ethyi-5-(trifluoromethyl)pyrimidine-2,4-diamine

SMILES

CCNC1=NC(NC2=CC(=NN2C3CC3)C(C)(C)N4N=CC=N4)=NC=C1C(F)(F)F

InChI

InChIKey=KMRYIKRXGJGPPB-UHFFFAOYSA-N
InChI=1S/C18H22F3N9/c1-4-22-15-12(18(19,20)21)10-23-16(27-15)26-14-9-13(28-29(14)11-5-6-11)17(2,3)30-24-7-8-25-30/h7-11H,4-6H2,1-3H3,(H2,22,23,26,27)

HIDE SMILES / InChI

Molecular Formula C18H22F3N9
Molecular Weight 421.4228
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 16:00:35 UTC 2023
Edited
by admin
on Sat Dec 16 16:00:35 UTC 2023
Record UNII
JB92FP7XER
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
N2-(3-(2-(2H-1,2,3-triazol-2-yl)propan-2-yl)-1-cyclopropyl-1H-pyrazol-5-yl)N4-ethyi-5-(trifluoromethyl)pyrimidine-2,4-diamine
Systematic Name English
2,4-Pyrimidinediamine, N<sup>2</sup>-[1-cyclopropyl-3-[1-methyl-1-(2H-1,2,3-triazol-2-yl)ethyl]-1H-pyrazol-5-yl]-N<sup>4</sup>-ethyl-5-(trifluoromethyl)-
Systematic Name English
N2-(2-CYCLOPROPYL-5-(1-METHYL-1-(TRIAZOL-2-YL)ETHYL)PYRAZOL-3-YL)-N4-ETHYL-5-(TRIFLUOROMETHYL)PYRIMIDINE-2,4-DIAMINE
Systematic Name English
N<sup>2</sup>-[1-Cyclopropyl-3-[1-methyl-1-(2H-1,2,3-triazol-2-yl)ethyl]-1H-pyrazol-5-yl]-N<sup>4</sup>-ethyl-5-(trifluoromethyl)-2,4-pyrimidinediamine
Systematic Name English
Code System Code Type Description
PUBCHEM
132232498
Created by admin on Sat Dec 16 16:00:35 UTC 2023 , Edited by admin on Sat Dec 16 16:00:35 UTC 2023
PRIMARY
FDA UNII
JB92FP7XER
Created by admin on Sat Dec 16 16:00:35 UTC 2023 , Edited by admin on Sat Dec 16 16:00:35 UTC 2023
PRIMARY
CAS
2170179-24-3
Created by admin on Sat Dec 16 16:00:35 UTC 2023 , Edited by admin on Sat Dec 16 16:00:35 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
DNL151 is a selective, orally bioavailable, central nervous system–penetrant, reversible inhibitor of leucine-rich repeat kinase 2 (LRRK2)